LATEST NEWS

November, 2012

Results of Annual General Meeting

Change of Director’s Interest Notice: Washer

Change of Director’s Interest Notice: Dantzker

Change of Director’s Interest Notice: Korten

Change of Director’s Interest Notice: Haghighat

Change of Director’s Interest Notice: MacDonald

October, 2012

iSonea Q1 Report 2013

ISN ASX Confirm Rights Issue Shortfall

Notice of Annual General Meeting and Explanatory Memorandum

Dispatch of Renounceable Pro-Rate Rights Issue Prospectus

iSonea Files FDA Submission for Over-the-Counter SonoSentry™

September, 2012

2012 Annual Report

Letter to Eligible Shareholders on Rights Issue

Letter to Ineligible Shareholders on Rights Issue

iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M

Appendix 3B: application for quotation of additional securities and agreement

Prospectus: Offer to Eligible Shareholders

Letter to Option Holders

iSonea App Now Free

 

 

 

Analyst Reports

 

January 2012

New Viriathus Healthcare Report Covers iSonea, January, 2012


 

RB Milestone Group:Promising Technology in an Attractive Industry

Full report

February 2011

Prestigious Analyst Group begins coverage of iSonea
(formerly iSonea)

Full report

 

Prestigious Analyst Group
begins coverage of iSonea (formerly iSonea)

Wise-Owl (www.wise-owl.com)

Full report

 

2009 RM Report

FDA Approvals, Wheezometer® sales commenced.

June 2008 RM Report

iSonea Limited Clinical Approvals Recieved, Sales and distribution to comence..

January 2008 RM Report

iSonea Limited  Maiden sales… FDA approval and CE Mark received...

© 2012 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin Processor
BlackFin® Processor
KarmelSonix ISO Certification
iSonea
ISO Certification 2003
US Food & Drug Administration

US Food & Drug Administration
Australian Government

Australian Government
Therapeutic Goods Administration


CE Certification

CE Certification